NCT02593747 - To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions

Histamine H1 Antagonists, Non-Sedating

Interventions

DRUG

Loratadine oral solution

Subjects received a single oral dose of 10 mg loratadine oral solution/syrup 1 mg/mL (GPLA formula, test formulation) under fasted condition in any intervention period.

DRUG

Loratadine (Claritin peach syrup)

Subjects received a single oral dose of 10 mg loratadine claritin peach syrup 1 mg/mL (ANNA formula, reference formulation) under fasted condition in any intervention period.

Trial Locations (1)

89231

Neu-Ulm